Literature DB >> 1703341

Correlation between bioassayed plasma levels of FK 506 and lymphocyte growth from liver transplant biopsies with histological evidence of rejection.

A Zeevi1, G Eiras, C Kaufman, M Alessiani, A J Demetris, K Abu-Elmagd, A Jain, V Warty, R Venkataramanan, G Burckart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1703341      PMCID： PMC2962597     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  12 in total

1.  Long-term (25-year) survival after renal homotransplantation--the world experience.

Authors:  T E Starzl; G P Schroter; N J Hartmann; N Barfield; P Taylor; T L Mangan
Journal:  Transplant Proc       Date:  1990-10       Impact factor: 1.066

2.  Pharmacokinetics of FK 506: preclinical and clinical studies.

Authors:  R Venkataramanan; A Jain; E Cadoff; V Warty; K Iwasaki; K Nagase; A Krajack; O Imventarza; S Todo; J J Fung
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

3.  Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations.

Authors:  A B Jain; R Venkataramanan; E Cadoff; J J Fung; S Todo; A Krajack; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

4.  Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A.

Authors:  A Zeevi; R Duquesnoy; G Eiras; H Rabinowich; S Todo; L Makowka; T E Starzl
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

5.  A highly sensitive method to assay FK-506 levels in plasma.

Authors:  K Tamura; M Kobayashi; K Hashimoto; K Kojima; K Nagase; K Iwasaki; T Kaizu; H Tanaka; M Niwa
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

6.  Allospecificity of activated T cells grown from endomyocardial biopsies from heart transplant patients.

Authors:  A Zeevi; J Fung; T R Zerbe; C Kaufman; B S Rabin; B P Griffith; R L Hardesty; R J Duquesnoy
Journal:  Transplantation       Date:  1986-05       Impact factor: 4.939

7.  FK 506 for liver, kidney, and pancreas transplantation.

Authors:  T E Starzl; S Todo; J Fung; A J Demetris; R Venkataramman; A Jain
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

8.  Kidney transplantation under FK 506.

Authors:  T E Starzl; J Fung; M Jordan; R Shapiro; A Tzakis; J McCauley; J Johnston; Y Iwaki; A Jain; M Alessiani
Journal:  JAMA       Date:  1990-07-04       Impact factor: 56.272

Review 9.  Liver allograft rejection: an overview of morphologic findings.

Authors:  A J Demetris; S G Qian; H Sun; J J Fung
Journal:  Am J Surg Pathol       Date:  1990       Impact factor: 6.394

10.  Propagation of lymphocytes infiltrating human liver allografts. Correlation with histologic diagnosis of rejection.

Authors:  S L Saidman; A J Demetris; A Zeevi; R J Duquesnoy
Journal:  Transplantation       Date:  1990-01       Impact factor: 4.939
View more
  4 in total

Review 1.  In vitro assessment of FK 506 immunosuppressive activity in transplant patients.

Authors:  A Zeevi; R Venkataramanan; V Warty; G Eiras; M Woan; K Abu-Elmagd; M Alessiani; A Jain; A J Demetris; T Zerbe
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

Review 2.  Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients.

Authors:  P E Wallemacq; R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 3.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

Review 4.  Clinical pharmacokinetics of tacrolimus.

Authors:  R Venkataramanan; A Swaminathan; T Prasad; A Jain; S Zuckerman; V Warty; J McMichael; J Lever; G Burckart; T Starzl
Journal:  Clin Pharmacokinet       Date:  1995-12       Impact factor: 6.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.